Envoy Medical (COCH) Capital Expenditures (2022 - 2025)

Envoy Medical has disclosed Capital Expenditures across 4 years of filings, most recently posting $172000.0 for Q4 2025.

• Capital Expenditures for Q4 2025 came in at $172000.0, up 132.21% year-over-year; the trailing twelve-month figure through Dec 2025 was $179000.0 (down 81.73% YoY), and the FY2025 annual result was $179000.0, down 81.73% from the prior year.
• Capital Expenditures came in at $172000.0 for Q4 2025 at Envoy Medical, up from $1000.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.2 million in Q3 2024 to a low of -$534000.0 in Q4 2024.
• The 4-year median for Capital Expenditures is $50000.0 (2022), against an average of $112750.0.
• Peak annual rise in Capital Expenditures reached 2154.55% in 2024, while the deepest fall reached 2642.86% in 2024.
• Envoy Medical's Capital Expenditures stood at $41000.0 in 2022, then tumbled by 48.78% to $21000.0 in 2023, then tumbled by 2642.86% to -$534000.0 in 2024, then jumped by 132.21% to $172000.0 in 2025.
• The last three Capital Expenditures figures came in at $172000.0 (Q4 2025), $1000.0 (Q2 2025), and $6000.0 (Q1 2025), per Business Quant data.